Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme

Sexually Transmitted Infections

Volumn 86, Issue SUPPL. 1, 2010, Pages

  Pickles, Michael ^a,b   Foss, Anna M ^b   Vickerman, Peter ^b   Deering, Kathleen ^c   Verma, Supriya ^d   Demers, Eric ^e   Washington, Reynold ^d,f,g   Ramesh, B M ^d,g   Moses, Stephen ^g   Blanchard, Jamie ^g   Lowndes, Catherine M ^b,e,h   Alary, Michel ^e   Reza Paul, Sushena ^g   Boily, Marie Claude ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d KARNATAKA HEALTH PROMOTION TRUST   (India)

^e LAVAL UNIVERSITY   (Canada)

^f ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^g UNIVERSITY OF MANITOBA   (Canada)

^h PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONDOM; CONTROLLED STUDY; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MODEL; PREVALENCE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROSTITUTION; SELF REPORT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ADULT; CONDOMS; DISEASE OUTBREAKS; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; INDIA; MALE; PROGRAM EVALUATION; PROSTITUTION; SAFE SEX;

EID: 77949894188     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2009.038950     Document Type: Article

References (80)

1. National AIDS Control Organisation, National Institute of Medical Statistics Ministry of Health and Family Welfare, Government of India. Technical report: India HIV estimates 2006. http://nacoonline.org/upload/ NACO PDF/Technical Report on HIV Estimation 2006.pdf (accessed 22 May 2009).
2. Avahan e the India AIDS initiative. The business of HIV prevention at scale. New Delhi: Bill & Melinda Gates Foundation, 2008. http://www.gatesfoundation.org/avahan/Documents/Avahan-HIVPrevention.pdf.
3. Moses S, Ramesh BM, Nagelkerke NJ, et al. Impact of an intensive HIV prevention programme for female sex workers on HIV prevalence among antenatal clinic attenders in Karnataka state, south India: an ecological analysis. AIDS 2008;22 (Suppl 5):S101-8.
4. Vickerman P, Foss AM, PicklesM, et al. Is the Indian HIV epidemic driven by commercial sex? A modelling analysis from south India. 18th ISSTDR: 28 Junee1 July 2009, London. http://www.isstdrlondon2009.com.
5. Chandrasekaran P, Dallabetta G, Loo V, et al. Evaluation design for large-scale HIV prevention programmes: the case of Avahan, the India AIDS initiative. AIDS 2008;22 (Suppl 5):S1-15.
6. Boily MC, Lowndes C, Alary M. The impact of HIV epidemic phases on the effectiveness of core group interventions: insights from mathematical models. Sex Transm Infect 2002;78(Suppl 1):i78-90.
7. Garnett GP, Gregson S, Stanecki KA. Criteria for detecting and understanding changes in the risk of HIV infection at a national level in generalised epidemics. Sex Transm Infect 2006;82(Suppl 1):i48-51.
8. Boily MC, Lowndes CM, Vickerman P, et al. Evaluating large-scale HIV prevention interventions: study design for an integrated mathematical modelling approach. Sex Transm Infect 2007;83:582-9.
9. Bradley JE, Moses S, Blanchard J, et al. Assessing reported condom use among female sex workers in southern India through examination of condom availability. Sex Transm Infect 2010;86(Suppl 1):i44-8.
10. Ramesh BM, Moses S, Washington R, et al. Determinants of HIV prevalence among female sex workers in four south Indian states: analysis of cross-sectional surveys in twenty-three districts. AIDS 2008;22(Suppl 5):S35-44.
11. Census of India. 2001. http://www.censusindia.net (accessed 19 May 2008).
12. Deering KN, Blanchard J, Moses S, et al. Characterising the factors associated with the numbers of client partners of female sex workers in south India: a geographic comparison. 18th ISSTDR; 28 Junee1 July 2009, London. http://www.isstdrlondon2009.com.
13. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001;28:579-97.
14. Foss AM, Vickerman PT, Chalabi Z, et al. Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty. Bull Math Biol 2009;71:720-49.
15. Garnett GP, Aral SO, Hoyle DV, et al. The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis 1997;24:185-200.
16. Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS 2002;13:91-101.
17. Cheong WK, Thirumoorthy T, Doraisingham S, et al. Clinical and laboratory study of first episode genital herpes in Singapore. Int J STD AIDS 1990;1:195-8.
18. Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983;98:958-72.
19. Corey L, Fife KH, Benedetti JK, et al. Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med 1983;98:914-21.
20. Corey L, Wald A. Genital herpes. Holmes KK, Mardh PA, Sparling PF, et al, eds. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999: 285-312.
21. Diamond C, Selke S, Ashley R, et al. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm Dis 1999;26:221-5.
22. Koelle DM, Benedetti J, Langenberg A, et al. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992;116:433-7.
23. Guinan ME, MacCalman J, Kern ER, et al. The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med 1981;304:759-63.
24. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131:14-20.
25. Wald A, Corey L, Cone R, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997;99:1092-7.
26. Wald A, Zeh J, Selke S, et al. Genital shedding of herpes simplex virus among men. J Infect Dis 2002;186(Suppl 1):S34-9.
27. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342:844-50.
28. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847-54.
29. Lafferty WE, Coombs RW, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-9.
30. Kim HN, Wald A, Harris J, et al. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study. Sex Transm Dis 2008;35:124-8.
31. Schacker T, Zeh J, Hu HL, et al. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 1998;178:1616- 22.
32. Conant MA, Schacker TW, Murphy RL, et al. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials. Int J STD AIDS 2002;13:12-21.
33. Grover G, Shivraj SO. Survival pattern of reported HIV infected individuals in the city of Delhi (India). J Commun Dis 2004;36:83-92.
34. Kumarasamy N, Solomon S, Flanigan TP, et al. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003;36:79-85.
35. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009;9:118-29.
36. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191:1403-9.
37. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-6.
38. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.
39. Wald A, Huang ML, Carrell D, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003;188:1345-51.
40. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970;91:170-4.
41. Mertz GJ, Schmidt O, Jourden JL, et al. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985;12:33-9.
42. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007;356:790-9.
43. Zuckerman RA, Lucchetti A, Whittington WL, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 2007;196:1500-8.
44. Baeten JM, Strick LB, Lucchetti A, et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 2008;198:1804-8.
45. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:2109-19.
46. Dunne EF, Whitehead S, Sternberg M, et al. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr 2008;49:77-83.
47. Delany S, Mlaba N, Clayton T, et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS 2009;23:461-9.
48. Schacker T, Hu HL, Koelle DM, et al. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. Ann Intern Med 1998;128:21-8.
49. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000;182:1090-6.
50. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995;123:845-7.
51. Nagot N, Foulongne V, Becquart P, et al. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women. J Acquir Immune Defic Syndr 2005;39:632-4.
52. LeGoff J, Weiss HA, Gresenguet G, et al. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes. AIDS 2007;21:1569-78.
53. Serwadda D, Gray RH, Sewankambo NK, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003;188:1492-7.
54. Nagot N, Ouedraogo A, Konate I, et al. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis 2008;198:241-9.
55. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9.
56. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004;35:435-45.
57. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83.
58. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008;358:1560-71.
59. Pinkerton SD, Abramson PR, Turk ME. Updated estimates of condom effectiveness. J Assoc Nurses AIDS Care 1998;9:88-9.
60. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997;44:1303-12.
61. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005;143:707-13.
62. Oberle MW, Rosero-Bixby L, Lee FK, et al. Herpes simplex virus type 2 antibodies: high prevalence in monogamous women in Costa Rica. Am J Trop Med Hyg 1989;41:224-9.
63. Dobbins JG, Mastro TD, Nopkesorn T, et al. Herpes in the time of AIDS: a comparison of the epidemiology of HIV-1 and HSV-2 in young men in northern Thailand. Sex Transm Dis 1999;26:67-74.
64. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 1999;179:16-24.
65. Huerta K, Berkelhamer S, Klein J, et al. Epidemiology of herpes simplex virus type 2 infections in a high-risk adolescent population. J Adolesc Health 1996;18:384-6.
66. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004;82:454-61.
67. Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. I: the risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978;108:136-44.
68. Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984;251:2822-4.
69. Barlow D. The condom and gonorrhoea. Lancet 1977;2:811-13.
70. Joesoef MR, Linnan M, Barakbah Y, et al. Patterns of sexually transmitted diseases in female sex workers in Surabaya, Indonesia. Int J STD AIDS 1997;8:576-80.
71. Sanchez J, Campos PE, Courtois B, et al. Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis 2003;30:273-9.
72. Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339:739- 44.
73. Niccolai LM, Rowhani-Rahbar A, Jenkins H, et al. Condom effectiveness for prevention of Chlamydia trachomatis infection. Sex Transm Infect 2005;81:323-5.
74. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis 1995;22:15-21.
75. Lowndes C, Alary M, Verma S, et al. Assessment of intervention outcome in the absence of baseline data: 'reconstruction' of condom use time trends using retrospective in analysis of survey data. Sex Transm Infect 2010;86:i49-55.
76. Weiss G, von Haeseler A. Inference of population history using a likelihood approach. Genetics 1998;149:1539-46.
77. Vickerman P, Platt L, Hawkes S. Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan. Sex Transm Infect 2009;85(Suppl 2):ii23-30.
78. Hallett TB, Gregson S, Mugurungi O, et al. Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to Zimbabwe. Epidemics 2009;1:108-17.
79. Karnataka Health Promotion Trust. About BIRDS. http://www.khpt.org/birds.htm (accessed 15 July 2009).
80. Boily MC, Pickles M, Vickerman P, et al. Using mathematical modelling to investigate the plausibility of attributing observed antenatal clinic declines to a female sex worker intervention in Karnataka state, India. AIDS 2008;22(Suppl 5):S149-64.